4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0000950170-24-083712
Chief Legal Officer sold 1,996 shares at $25.00 ($49,900)
- Chief Legal Officer acquired 1,996 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bizily Scott Chief Legal Officer | 2024-07-11 | Option exercise 10b5-1 | +1,996 | $15.78 | $31,497 | 8,777 | D |
| Bizily Scott Chief Legal Officer | 2024-07-11 | Sale 10b5-1 | −1,996 | $25.00 | $49,900 | 6,781 | D |
| Derivatives | |||||||
| Bizily Scott Chief Legal Officer | 2024-07-11 | Option exercise · Stock Option (Right To Buy) 10b5-1 | −1,996 | 23,004 | D | ||
| Open-market sales · 1,996 sh · avg $25.00 · $49,900 | |||||||
Loading xslF345X05/ownership.xml…